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1. Introduction
   An elevated serum progesterone (EP) concentration on the day of 
ovulatory trigger was first reported in the early 1990’s[1], showing 
an adverse impact on the pregnancy outcome following in vitro 
fertilization (IVF) treatment. However, no conclusive consensus 
has been achieved in the last two decades due to inconsistent 
conclusions drawn by a large number of publications as summarized 
in a few recent meta-analysis review articles[2-4]. Furthermore, 
the controversy is also illustrated in these reviews as they came 
up with different conclusions depending on the period reviewed, 
reflecting continued debate between the emerging papers[2-4]. 
Objective:  To investigate the relationship between elevated serum progesterone levels (EP) on 
the day of ovulatory trigger, live birth rates, and the growth of resulting embryos. Methods: A 
total of 836 in vitro fertilization (IVF) cycles with 4 478 embryos in conventional culture were 
retrospectively analyzed, together with an additional 90 IVF cycles producing 618 embryos 
from culture and assessment using the Embryoscope™ time-lapse system. Results: In cycles 
using conventional culture, serum progesterone per follicle ≥曒14 mm (median 0.42 nmol/L/
follicle, range 0.05-3.50 nmol/L/follicle) was a significant negative predictor of live-birth (ROC 
AUC = 0.395, 95% CI 0.345-0.445; P=0.000) as were progesterone/estradiol ratio (0.442, 
0.391-0.494; P=0.027) and progesterone per oocyte (0.374, 0.326-0.421; P=0.000) but not 
progesterone alone (0.470, 0.419-0.521; P>0.05). Women with an EP/follicle (>0.42 nmol/
L/follicle) had reduced live birth rates if they were ≥曒35 yrs (14.4% vs. 24.2%, P<0.05) but 
not <35 years (35.3% vs. 37.4%, ns). Despite reduced pregnancy rates, cycles with EP/follicle 
in women ≥曒35 years produced similar proportions of “good” and “top” quality embryos in 
conventional culture compared to women with low progesterone/follicle, and no difference 
in abnormalities of cleavage (direct cleavage or reverse cleavage), multinucleation or timings 
of division (pronuclear fading to 2-cell, 3-cell, 4-cell and 5-cell; cc2 and S2) observed with 
time-lapse videography. Conclusions: EP/follicle ≥曒14 mm (>0.42 nmol/L/follicle) adversely 
affects embryo implantation in women aged ≥曒35 years, but not <35 yrs. However, no adverse 
features were seen in the embryos from these affected cycles in terms of morphological 
appearance, abnormal patterns of cleavage, or morphokinetic timings.
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Although the exact mechanism behind EP is still not clear[5, 6], 
the adverse impact of EP on the endometrial environment was 
supported by both direct[7-9] and indirect[3, 10] evidence. Whilst 
the majority of previous studies focussed on this apparent effect 
of endometrial asynchronicity, several have investigated the effect 
of EP on the quality of subsequent embryos via either direct static 
observations[11], indirect evidence with the use of subsequent 
frozen embryo transfer cycles[3, 10-12] or separation of the embryo 
and endometrium by studying donor oocyte cycles[3, 13]. Again, 
the conclusions were inconsistent, suggesting possible variability 
between different populations of patients, a limitation or insensitivity 
in the methods used to detect differences between embryos, or a 
combination of the two.
   The developmental performance of embryos during in vitro culture 
is associated with both maternal and paternal factors. The use of 
implantation rates as an end-point is only informative about the best 
embryos that were selected for transfer, whereas the examination 
of the whole population of embryos obtained following controlled 
ovarian stimulation may well help to assess the full impact upon 
oocyte quality of a potentially disturbed hormonal milieu. In 
addition, paternal confounding factors are more likely to be present 
in intracytoplasmic sperm injection (ICSI) cycles if the treatment 
is indicated due to abnormal semen quality. Indeed, time-lapse 
study has shown the abnormal growth pattern of reverse cleavage 
(RC) following ICSI to be associated with reduced progressive 
sperm motility[14]. The vast majority of recently published large-
scale retrospective studies regarding EP, each with more than 1 000 
cycles analyzed, included a mixture of conventional IVF and ICSI 
cycles [10-12, 15-18] thereby failing to acknowledge the confounding 
variable of semen quality. The effect of male factors could be largely 
eliminated if conventional IVF cycles alone were considered when 
using embryo development to reflect oocyte quality. Furthermore, 
time-lapse imaging has recently been introduced into human 
IVF practice providing more information about embryo growth 
through continuous monitoring[19]. Timing the parameters of early 
embryonic developmental events have been successfully linked with 
blastulation[20], euploidy status[20, 21], and implantation results[19], 
with abnormal cleavage division patterns of observed embryos also 
being associated with subsequent implantation potential[14, 22, 23]. 
Time-lapse videography would be ideally suited to assess embryos 
derived from oocytes obtained from different hormonal milieu.
   The aims of the present study were therefore to 1) restrict analysis 
to IVF cycles to minimize paternal confounding variables, 2) 
determine the impact of EP upon live birth rates, 3) assess embryo 
quality in IVF cycles using both conventional and time-lapse culture 
systems, and 4) examine the relationship between embryo growth 
and the level of progesterone in maternal serum seen on the day of 
ovulatory trigger.
2. Materials and methods
2.1. Patient management and gamete collection
   Conventional embryology data were collected retrospectively 
from 617 patients with a total of 836 conventional IVF treatment 
cycles performed at 3 participating clinics, between January 2007 
and June 2013. Retrospective morphokinetic embryology data were 
obtained using the Embryoscope™ at one of these 3 clinics between 
July 2013 and October 2014, with a total of 90 IVF cycles included. 
Retrospective data analysis has been approved by the institutional 
research ethics committees, and informed consent was provided by 
both partners of couples using Embryoscope™ as the culture option 
for the embryos. 
   Pituitary suppression was administrated in the female patients 
with the use of either GnRH agonist or antagonist as previously 
described[14]. Serum progesterone level was measured on the day 
of ovulatory trigger in all 3 laboratories using Siemens Centaur 
CP automated analyzers, and the number of ovarian follicles with 
a diameter ≥曒14 mm determined by transvaginal ultrasonography 
was noted. The oocyte-cumulus complexes (OCC) were collected 
under ultrasound guidance thirty-six hours after the ovulatory trigger 
injection with hCG, either 10 000 IU Pregnyl (Organon) or 500 IU 
Ovidrel (Merck Serono). Sperm samples were processed within 2 
hours of oocyte collection from samples either collected by the male 
partners via masturbation with an abstinence period of 2-5 days, 
or thawed from cryopreserved donor samples. Sperm with good 
motility were separated from fresh ejaculates or the post-thaw frozen 
samples with the use of 95%:50% density gradients (Puresperm, 
Nidacon) centrifugation. Four to six hours post oocyte collection, 
the OCCs were mixed with the prepared sperm sample at a ratio of 
50 000 sperm per oocyte, with a maximum 5 OCCs per dish, being 
co-incubated overnight within a tri-gas regulated MINC incubator 
(Cook Medical, Queensland, Australia) at 37 曟. Fertilization 
was confirmed by the visualization of two pronuclei (2PN) 16-18 
hours post insemination. Fertilized oocytes were then transferred to 
different types of incubators for further culture before replacement 
or storage.
   One or two embryos were transferred on day 2, 3 or 5 after 
insemination depending on availability of embryo selection and 
treatment plan. All cycles with a positive pregnancy test (serum 毬
hCG> 25 iu/L) 14 days after oocyte collection were followed up and 
the outcome of the pregnancy confirmed. Live birth rates were used 
to indicate a successful treatment outcome.
2.2. Embryology in MINC incubators
   Fertilized oocytes were incubated in MINC incubators using pre-
mixed gas (6% CO2, 5% O2, balance N2) for 2 to 5 days of culture 
before replacement or storage. Embryos were observed daily for 
grading. A simple coding system has been employed which allows 
for more consistency between operators and between clinics. The 
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embryologist records the date and time of the observation and the 
number of intact blastomeres seen. The embryologist estimates the 
embryos as symmetrical or asymmetrical and also estimates the 
degree of fragmentation into 3 possible categories (<10%, 10%-40% 
and >40% of the total volume of the embryo). A computer algorithm 
then grades each embryo into 4 possible grades with grade 1 being 
the best and grade 4 the worst quality embryos. This grading is based 
primarily on the principle of on-time cleavage and most emphasis 
is placed on this factor. Each embryology code is assigned a grade 
in priority order of cell numbers, fragmentation and symmetry. This 
system is a rudimentary morphokinetic system of grading.
2.3. Embryology in Embryoscope™ time-lapse incubator
   Fertilized oocytes were loaded into Embryoscope™ time-
lapse incubator perfused with 6% CO2, 5% O2, balance N2 as 
described previously[14] with images taken every 10 mins at 7 focal 
planes. Morphokinetic analysis of embryos was performed with 
the Embryoviewer® software, with time from insemination to 
pronuclear fading (tPNF), time from PNF to 2-(t2_pnf), 3-(t3_pnf), 
4-(t4_pnf), and 5-cell (t5_pnf) stages, and time intervals between 
cell stages such as cc2 (t3-t2) and s2 (t4-t3) recorded. Abnormal 
biological events were also noted, including multinucleation (MN) 
in at least one blastomere at the 2- or 4-cell stage, RC as described in 
a previous publication[14], and direct cleavage 2-3 cells (DC) which 
is defined as cc2<5 hours[23]. 
2.4. Statistical analysis
   Proportion data were analyzed via Chi square or Fisher exact test. 
The predictive value of continuous data on live birth outcome was 
assessed with the use of the receiver operating characteristic (ROC) 
and area under the ROC curve (AUC) with 95% Confidence Interval 
(CI). Continuous data were expressed as mean±SD, and compared 
via student t-test. All statistical analysis was carried out with the 
use of the Statistical Package for the Social Sciences 20.0 (SPSS). 
P<0.05 was considered statistically significant.
3. Results
3.1. Live birth rates and choice of progesterone threshold
   AUC [95% CI] showed the overall occurrence of live birth could 
not be predicted at the time of ovulatory trigger by the serum 
progesterone concentration alone (AUC=0.470 [0.419-0.521], 
P>0.05). However, negative predictors of live birth were the 
progesterone/estradiol ratio (AUC=0.442 [0.391-0.494], P=0.027), 
progesterone per follicle ≥曒14 mm (AUC=0.395 [0.345-0.445], 
P=0.000) and progesterone per oocyte (AUC=0.374 [0.326-0.421], 
P=0.000). Of the two strongest predictors, progesterone per follicle 
had the advantage that the information was available before the 
woman underwent surgery for the collection of oocytes, and was 
calculated using follicle number and size which is widely used to 
time the ovulatory trigger. Progesterone per follicle was therefore 
used in subsequent analyses with the median concentration of 0.42 
nmol/L/follicle being chosen as the arbitrary threshold to separate 
high and low values. Further examination of the live birth rates 
per transfer, taking into account the women’s age, is shown in 
Table 1. Women ≥曒35 years had significantly reduced live birth 
rates compared to those <35 years whether the progesterone per 
follicle was low or high. Whilst rates were similar for the younger 
women between the two progesterone groups, the live birth rate 
per transfer for the older women was significantly reduced when 
the progesterone per follicle was high compared to their low 
progesterone counterparts.
Table 1
Live birth rates for women with low (曑0.42 nmol/L/follicle) or high 
(>0.42 nmol/L/follicle) progesterone per follicle ≥曒14 mm on the 
day of ovulatory trigger according to their age at egg collection.
Age
Progesterone (nmol/L/follicle)
Total
≤曑0.42 >0.42
敿35 years 40/107 (37.4%)
c 18/51 (35.3%)d 58/158 (36.6%)e
曒35 years 58/240 (24.2%)
ac 42/291 (14.4%)ad 100/531 (18.8%)e
Total 98/347 (28.2%)b 60/342 (17.5%)b 158/689 (22.9%)
a-eGroups with same superscript are significantly different, P<0.05.
3.2. Prevalence of high progesterone per follicle
   Table 2 shows the prevalence of EP/follicle on the day of ovulatory 
trigger in 617 patients according to the number of repeat treatment 
cycles. Approximately half (314/617, 50.9%) of the women 
experienced an elevated progesterone per follicle in at least one 
cycle. Of the 137 women having two or more cycles, 48 (35.0%) 
were affected by EP in all repeat cycles. 
Table 2 
Prevalence of elevated serum progesterone concentration per follicle 曒14 mm(>0.42 nmol/L/follicle) on the day of ovulatory trigger in 836 
IVF cycles from 617 patients and its incidence in repeat treatment cycles.
Number of patients 
Number of repeat cycles (%)
Total
1 cycle 2 cycles 3 cycles ≥曒4 cycles
Nil cycles affected 265 29 7 2 303 (49.1%)
1 cycle affected by high progesterone 215 29 7 2 253 (41.0%)
2 cycles affected by high progesterone - 27 10 1 38 (6.2%)
3 cycles affected by high progesterone - - 10 2 12(1.9%)
4 cycles affected by high progesterone - - - 11 11(1.8%)
Total 480 (77.8%) 85 (13.8%) 34 (5.5%)         18 (2.9%)    617 (100.0%)
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3.3. Patients and cycles
   Table 3 demonstrates the clinical features and outcomes of all 836 
IVF cycles using conventional embryo culture. In both age groups 
(<35 and ≥曒35 years), the EP/follicle group was significantly older, 
had a significantly lower serum oestradiol concentration, higher 
serum progesterone concentration, and lower number of oocytes 
collected, although there was no difference in the proportion of 
oocytes fertilized. 
3.4. Embryo quality and growth 
   As shown in Table 3, the younger women with EP/follicle had a 
significantly higher proportion of embryos with better morphology 
but no difference in the proportion that gave rise to live babies. 
Conversely, the older women with EP/follicle had similar embryo 
quality to their low progesterone counterparts but a reduced 
proportion that went on to become a baby. Table 4 shows the embryo 
development and incidences of abnormal biological events which 
Table 3
Clinical features and outcomes of 836 IVF cycles between January 2007 and June 2013 according to whether or not serum progesterone (P4) 
concentration per follicle ≥曒14 mm was high (>0.42 nmol/L/follicle) or not on the day of ovulatory trigger. 
Parameters
<35 years ≥曒35 years
P4/follicle曑0.42 P4/follicle>0.42 P4/follicle曑0.42 P4/follicle >0.42
No. cycles 129 68 291 348
No. Agonist cycles (%) 63(48.8) 42(61.8) 143(49.1) 192(55.2)
No. Antagonist cycles (%) 66(51.2) 26(38.2) 148(50.9) 156(44.8)
Age of women (years, mean±SD) 31.3±2.8a 32.5±2.0a  39.1±2.6g 40.1±2.8g
Peak E2 (pmol/L, mean±SD) 7 266±4 546  6 279±4 293    6 763±3 992h   4 946±3 412h
Days of FSH (mean±SD) 11.0±2.1b 12.0±3.9b 11.0±2.4 11.1±2.0
P4 ( nmol/L,  mean±SD)   2.3±1.1c   3.8±2.1c    2.3±1.1i   3.4±1.8i
No. oocytes collected (mean±SD) 12.2±6.4d   8.7±6.1d   10.4±5.9j   6.1±4.4j
Total No. oocytes collected 1568 592 3022 2122
No. oocytes fertilized (%) 1 027(65.5) 376(63.5) 1 792(59.3) 1 283(60.5)
No. Top quality embryos (%) 424(41.3)e 184(48.9)e 766(42.7) 579(45.1)
No. Good quality embryos (%) 576(56.1)f 245(65.2)f 1 026(57.3) 773(60.2)
No. embryo transfers 107 51 240 291
No. embryos transferred 130 60 335 421
No. babies born (%) 45(34.6) 21(35.0) 61(18.2)k 46(10.9)k
a-kValues with same superscript are significantly different, P<0.05. 
Table 4 
Embryo development and incidences of abnormal biological events of embryos cultured in an Embryoscope™ time-lapse incubator from an 
additional 90 IVF cycles between July2013 and October 2014 according to whether or not serum progesterone (P4) concentration per follicle 
≥曒14 mm was high (>0.42 nmol/L/follicle) or not on the day of ovulatory trigger.
Parameters
<35 years ≥曒35 years 
P4/follicle曑0.42 P4/follicle>0.42 P4/follicle曑0.42 P4/follicle>0.42
No. embryos 265 94 144 115
No. embryos ≥ 曒6 cells by day 3(%) 192(72.5) 63(67.0) 94(65.3) 69(60.0)
Reverse cleavage (RC) (%) 58(21.9) 20(21.3) 36(25.0) 30(26.1)
Direct cleavage (DC) (%) 8/237(3.4) 3/85(3.5) 11/131(8.4) 6/96(6.3)
Multinucleation@2-cell (%) 60/254(23.6) 23/90(25.6) 35/143(24.5) 34/109(31.2)
Multinucleation@4-cell (%) 17/226(7.5) 7/83(8.4) 13/123(10.6) 8/87(9.2)
tPNF (n) 24.2±2.9(256)a 27.0±5.6(88)a    25.9±3.7(133)f  24.7±3.5(106)f
t2_pnf (n)  3.9±4.8(246)  3.2±2.8(87)     3.8±4.0(132)    3.8±3.9(103)
t3_pnf (n)  14.0±3.0(229)b  15.2±3.7(82)b   15.4±4.1(120)  15.0±3.6(90)
t4_pnf (n)  15.3±4.4(218)c  16.6±4.2(80)c   16.5±5.0(114)  16.0±4.2(81)
t5_pnf (n)  25.3±3.7(196)d  27.9±4.5(71)d 27.4±3.9(95)  27.6±3.1(71)
cc2 (t3-t2) (n)  10.8±1.7(229)e  12.0±2.0(82)e   12.1±3.0(120)  11.8±2.7(90)
s2 (t4-t3) (n)   1.5±3.3(218)   1.8±3.5(80)      1.6±3.2(114)    1.7±3.3(81)
Proportion of embryos with DC in each group was based on the number of embryos that had completed 3-cell stage; Proportion of embryos 
with multinucleation at 2- or 4-cell stage in each group was based on the number of embryos that have reached 2- or 4-cell stage respectively; 
Timing parameters are expressed as mean±SD in hours, and embryos with direct cleavage were excluded; a-fValues with same superscript are 
significantly different, P<0.05.
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were detected by the time-lapse analysis in a further 90 IVF cycles. 
There was no difference for either age range between the high and 
low progesterone/follicle groups for the proportion of embryos 
reaching ≥曒6 cells by Day 3, or showing abnormal patterns of 
cleavage namely reverse cleavage, direct cleavage or multinucleation. 
However, EP/follicle in the younger women was associated with a 
slower time from insemination to PNF, slower times from PNF to 
3-cell, 4-cell and 5-cell, and an extended cell cycle time from 2- to 
3-cell. For the older age range, EP/follicle was associated with a 
quicker time from insemination to PNF but all other morphokinetic 
parameters were similar.
4. Discussion
   EP is a potentially abnormal hormonal profile which has 
received much attention over the years. Originally thought to be a 
result of premature luteinisation[24], EP can occur in the presence 
of low LH[25], although reduced implantation can occur with the 
advancing of the endometrium by elevated circulating progesterone 
in the absence of a classical LH surge[26]. There are many definitions 
of EP used by different authors, and the prevalence varies according 
to the cut-off values used for the progesterone level[3, 10] although 
one must be cautious about comparing thresholds as different 
commercial progesterone assays do show different performance 
characteristics [27, 28],  the expression of progesterone concentration 
on its own or as a ratio with estradiol[29], and the population of 
women investigated [11, 12, 16, 17, 30-33]. Furthermore, the degree of 
ovarian response has been identified as a factor in affecting the impact 
of EP, with a sliding scale of cut-off values being proposed according 
to the number of oocytes collected[11, 15]. The present study did not see 
a clear clinical effect of elevated progesterone alone, but the effect of 
EP expressed per follicle did and this may well reflect the influence of 
the ovarian response (as gauged by the number of follicles ≥曒14mm) 
when used as a denominator. This adjustment allowed a clearer 
analysis of pregnancy rates according to age, and indeed an EP/
follicle was seen to be associated with lower implantation rates in 
the older women but not the younger women. Apart from examining 
the prevalence of EP in consecutive treatment cycles, the present 
study also investigated its occurrence in the repeat cycles of the same 
patients. Only 48/137 (35.0%) women were affected by EP in all 
cycles suggesting that the phenomenon is cycle rather than patient 
specific.
   Whilst high progesterone levels have been shown to affect oocyte 
maturation in-vitro using a mouse model[34], the effect on oocytes 
and embryos of elevated progesterone in the human is not clear. 
Using oocyte donors and recipients as a means of separating the 
potential effects of progesterone upon oocyte and endometrium, 
pregnancy rates in the recipients were either not affected[35, 36] 
or even improved[37]. The examination of subsequent frozen 
embryo transfer in patients has also been used to try and separate 
the potential effects in the original cycle, and a simple analysis of 
pregnancy rates showed no difference when the embryos originated 
from a high progesterone cycle[38], but a more comprehensive appraisal 
of cumulative pregnancy rates did show a significant reduction in 
implantation with embryos exposed to a higher progesterone level in 
the original cycle[15]. Whilst there has been very little in the literature 
looking at the impact of elevated progesterone on embryo development 
other than blastulation rates [39], the present study has shown using 
continuous monitoring during culture within the Embryoscope™ 
time-lapse incubator no evidence of embryo morphokinetics usually 
indicative of reduced implantation potential in the older women 
despite a reduced pregnancy rate. Indeed, there was a short time to 
PNF in the older EP/follicle group and this is allegedly associated 
with either better subsequent embryo quality judged by time-lapse 
monitoring[40, 41] or higher implantation potential in a conventional 
embryo culture system[42]. There was also no difference in the 
occurrence of abnormal patterns of cleavage associated with reduced 
implantation potential such as multinucleation[43-45] and reverse 
cleavage[14]. 
   In conclusion, EP/follicle ≥曒14 mm adversely affects embryo 
implantation in women aged ≥曒35 years, but not <35 yrs. However, 
no adverse features were seen in the embryos from these affected 
cycles in terms of morphological appearance, abnormal patterns of 
cleavage, or morphokinetic timings.
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